266 related articles for article (PubMed ID: 26081022)
1. Abnormal Wnt signaling and overexpression of ABCG2 contributes to drug efflux properties of side population cells in nasopharyngeal carcinoma.
Guan GF; Zhang DJ; Zheng Y; Wen LJ; Yu DJ; Lu YQ; Zhao Y
Mol Med Rep; 2015 Sep; 12(3):4352-4357. PubMed ID: 26081022
[TBL] [Abstract][Full Text] [Related]
2. Isolation and phenotypic characterization of cancer stem like cells from nasopharyngeal carcinoma.
Wang Y; Zhang GH; Li SL
Drug Res (Stuttg); 2015 Jun; 65(6):323-6. PubMed ID: 25207708
[TBL] [Abstract][Full Text] [Related]
3. Tumor recurrence and drug resistance properties of side population cells in high grade ovary cancer.
Zhang QH; Dou HT; Xu P; Zhuang SC; Liu PS
Drug Res (Stuttg); 2015 Mar; 65(3):153-7. PubMed ID: 25504004
[TBL] [Abstract][Full Text] [Related]
4. ABCG2-meditated multidrug resistance and tumor-initiating capacity of side population cells from colon cancer.
Xie ZY; Lv K; Xiong Y; Guo WH
Oncol Res Treat; 2014; 37(11):666-8, 670-2. PubMed ID: 25427584
[TBL] [Abstract][Full Text] [Related]
5. Tumor formation and drug resistance properties of human glioblastoma side population cells.
Chen D
Mol Med Rep; 2015 Jun; 11(6):4309-14. PubMed ID: 25633829
[TBL] [Abstract][Full Text] [Related]
6. Isolation and characterization of cancer stem cells from medulloblastoma.
Liu J; Chi N; Zhang JY; Zhu W; Bian YS; Chen HG
Genet Mol Res; 2015 Apr; 14(2):3355-61. PubMed ID: 25966102
[TBL] [Abstract][Full Text] [Related]
7. Multidrug resistance and tumor-initiating capacity of oral cancer stem cells.
Shang HG; Yu HL; Ma XN; Xu X
J BUON; 2016; 21(2):461-5. PubMed ID: 27273959
[TBL] [Abstract][Full Text] [Related]
8. [Analysis of the characteristics of side population cells in the human ovarian cancer cell line OVCAR-3].
Luo LJ; Zhao Z; Zeng JF; Liang B; Yang JX; Cao DY; Shen K
Zhonghua Fu Chan Ke Za Zhi; 2012 Apr; 47(4):281-5. PubMed ID: 22781115
[TBL] [Abstract][Full Text] [Related]
9. Biologic characteristics of the side population of human small cell lung cancer cell line H446.
Wang B; Yang H; Huang YZ; Yan RH; Liu FJ; Zhang JN
Chin J Cancer; 2010 Mar; 29(3):254-60. PubMed ID: 20193106
[TBL] [Abstract][Full Text] [Related]
10. Elevated Expression of Nrf-2 and ABCG2 Involved in Multi-drug Resistance of Lung Cancer SP Cells.
Yang B; Ma YF; Liu Y
Drug Res (Stuttg); 2015 Oct; 65(10):526-31. PubMed ID: 25368906
[TBL] [Abstract][Full Text] [Related]
11. The PI3K/AKT signaling pathway regulates ABCG2 expression and confers resistance to chemotherapy in human multiple myeloma.
Wang L; Lin N; Li Y
Oncol Rep; 2019 Mar; 41(3):1678-1690. PubMed ID: 30664164
[TBL] [Abstract][Full Text] [Related]
12. Isolation and characterization of cancer stem-like side population cells in human oral cancer cells.
Yanamoto S; Kawasaki G; Yamada S; Yoshitomi I; Kawano T; Yonezawa H; Rokutanda S; Naruse T; Umeda M
Oral Oncol; 2011 Sep; 47(9):855-60. PubMed ID: 21757396
[TBL] [Abstract][Full Text] [Related]
13. Side population cells and drug resistance in breast cancer.
Wang M; Wang Y; Zhong J
Mol Med Rep; 2015 Jun; 11(6):4297-302. PubMed ID: 25647733
[TBL] [Abstract][Full Text] [Related]
14. In vitro and ex vivo anti‑tumor effect and mechanism of Tucatinib in leukemia stem cells and ABCG2‑overexpressing leukemia cells.
Jing W; Zhou M; Chen R; Ye X; Li W; Su X; Luo J; Wang Z; Peng S
Oncol Rep; 2021 Mar; 45(3):1142-1152. PubMed ID: 33650639
[TBL] [Abstract][Full Text] [Related]
15. Regulation of stem-like cancer cells by glutamine through β-catenin pathway mediated by redox signaling.
Liao J; Liu PP; Hou G; Shao J; Yang J; Liu K; Lu W; Wen S; Hu Y; Huang P
Mol Cancer; 2017 Feb; 16(1):51. PubMed ID: 28245869
[TBL] [Abstract][Full Text] [Related]
16. ABCG2 inhibitor YHO-13351 sensitizes cancer stem/initiating-like side population cells to irinotecan.
Shishido Y; Ueno S; Yamazaki R; Nagaoka M; Matsuzaki T
Anticancer Res; 2013 Apr; 33(4):1379-86. PubMed ID: 23564776
[TBL] [Abstract][Full Text] [Related]
17. Identification of ABCG2⁺ cells in nasopharyngeal carcinoma cells.
Zhang H; Liu W; Feng X; Wang L; Jiang X; Liu D; Zhang L; Zhu B; Zhou W; Jia W; Li G; Ren C
Oncol Rep; 2012 Apr; 27(4):1177-87. PubMed ID: 22209971
[TBL] [Abstract][Full Text] [Related]
18. The multidrug resistance transporter ABCG2 (breast cancer resistance protein 1) effluxes Hoechst 33342 and is overexpressed in hematopoietic stem cells.
Kim M; Turnquist H; Jackson J; Sgagias M; Yan Y; Gong M; Dean M; Sharp JG; Cowan K
Clin Cancer Res; 2002 Jan; 8(1):22-8. PubMed ID: 11801536
[TBL] [Abstract][Full Text] [Related]
19. Hedgehog signaling regulates drug sensitivity by targeting ABC transporters ABCB1 and ABCG2 in epithelial ovarian cancer.
Chen Y; Bieber MM; Teng NN
Mol Carcinog; 2014 Aug; 53(8):625-34. PubMed ID: 23423781
[TBL] [Abstract][Full Text] [Related]
20. Aberrant activation of Wnt/catenin signaling and overexpression of ABCG2 contributes to apoptosis down regulation and tumor progression of high grade ovarian cancer.
Gui Z; Yan H; Wu J; Zhang M; Wu A; He J
Acta Biochim Pol; 2021 Feb; 68(1):127-133. PubMed ID: 33635609
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
